Mast cells have been implicated in the expression of a wide variety of biological responses, including IgE-dependent immediate hypersensitivity reactions, host responses to parasites and neoplasms, and many immunologically non-specific inflammatory processes. While these responses are initiated by distinct stimuli, most of them share common characteristics such as alterations of vascular permeability, recruitment of blood-borne leukocytes, and activation of interstitial fibrin deposition. However, the molecular basis for many of the proposed actions of mast cells in these inflammatory or immunological responses has remained obscure. During the previous funding period of this project, we identified a new mechanism by which mast cells might importantly influence multiple aspects of IgE-dependent or -independent biological responses: the production of a broad panel of multifunctional cytokines, including TNF-alpha, IL-1alpha, IL-3, IL-4, IL-5, IL-6, GM-CSF, MIP-1alpha MIP1-beta, TCA3, JE, IFN-gamma, and TGF-beta. However, virtually all of the published information about mast cell cytokine production, from both our own and other laboratories, has been derived from analyses of mast cells generated in vitro, which express many phenotypic differences from mast cell populations which occur in situ. In fact, the only data available concerning cytokine production by mature, freshly isolated mast cells are derived from our studies of mouse peritoneal mast cells, which constitutively contain significant amounts of TNF-alpha that can be released upon appropriate stimulation. But the ability of these cells to produce other cytokines has not been reported. Moreover, no published studies have evaluated the biological significance of mast cell cytokine production in vivo. We therefore now wish to determine whether mast cell populations in vivo represent a significant source of multifunctional cytokines, and to evaluate the extent to which the production of TNF-alpha and other cytokines can account for specific actions of mast cells in inflammatory or immunological responses in vivo. The patterns of cytokine production induced by various biologically significant stimuli of mast cell activation will be assessed in populations of in vitro-derived and freshly isolated mature mouse mast cells. The same stimuli will then be tested in vivo, and patterns of mast cell cytokine production will be assessed by tissue Northern analysis, in situ hybridization, immunohistochemistry, and assays of tissues for certain cytokine bioactivities. The contributions of mast cell-derived cytokines, as opposed to cytokines derived from other cell types, in specific inflammatory or immunological responses will be assessed by comparing the expression of cytokine-dependent aspects of these responses in genetically mast cell-deficient W/Wv or Sl/Sld mice, the congenic normal (+/+) mice, and W/Wv mice repaired of their mast cell deficiency by adoptive transfer of mast cells of congenic +/+ origin.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI022674-10
Application #
2061941
Study Section
Allergy and Immunology Study Section (ALY)
Project Start
1986-05-01
Project End
1996-04-30
Budget Start
1995-05-01
Budget End
1996-04-30
Support Year
10
Fiscal Year
1995
Total Cost
Indirect Cost
Name
Beth Israel Deaconess Medical Center
Department
Type
DUNS #
076593722
City
Boston
State
MA
Country
United States
Zip Code
02215
Rosenkranz, A R; Coxon, A; Maurer, M et al. (1998) Impaired mast cell development and innate immunity in Mac-1 (CD11b/CD18, CR3)-deficient mice. J Immunol 161:6463-7
Kendall, J C; Li, X H; Galli, S J et al. (1997) Promotion of mouse fibroblast proliferation by IgE-dependent activation of mouse mast cells: role for mast cell tumor necrosis factor-alpha and transforming growth factor-beta 1. J Allergy Clin Immunol 99:113-23
Hill, P B; MacDonald, A J; Thornton, E M et al. (1996) Stem cell factor enhances immunoglobulin E-dependent mediator release from cultured rat bone marrow-derived mast cells: activation of previously unresponsive cells demonstrated by a novel ELISPOT assay. Immunology 87:326-33
Taylor, A M; Galli, S J; Coleman, J W (1996) Dexamethasone or cyclosporin A inhibits stem cell factor-dependent secretory responses of rat peritoneal mast cells in vitro. Immunopharmacology 34:63-70
Samet, J M; Fonteh, A N; Galli, S J et al. (1996) Alterations in arachidonic acid metabolism in mouse mast cells induced to undergo maturation in vitro in response to stem cell factor. J Allergy Clin Immunol 97:1329-41
London, C A; Kisseberth, W C; Galli, S J et al. (1996) Expression of stem cell factor receptor (c-kit) by the malignant mast cells from spontaneous canine mast cell tumours. J Comp Pathol 115:399-414
Schmidt-Choudhury, A; Furuta, G T; Lavigne, J A et al. (1996) The regulation of tumor necrosis factor-alpha production in murine mast cells: pentoxifylline or dexamethasone inhibits IgE-dependent production of TNF-alpha by distinct mechanisms. Cell Immunol 171:140-6
Wershil, B K; Furuta, G T; Lavigne, J A et al. (1995) Dexamethasone or cyclosporin A suppress mast cell-leukocyte cytokine cascades. Multiple mechanisms of inhibition of IgE- and mast cell-dependent cutaneous inflammation in the mouse. J Immunol 154:1391-8
Galli, S J; Wershil, B K (1995) Mouse mast cell cytokine production: role in cutaneous inflammatory and immunological responses. Exp Dermatol 4:240-9
Wershil, B K; Furuta, G T; Lavigne, J A et al. (1995) Dexamethasone and cyclosporin A suppress mast cell-leukocyte cytokine cascades by multiple mechanisms. Int Arch Allergy Immunol 107:323-4

Showing the most recent 10 out of 79 publications